First RSV vaccine approved for older adults
The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV) in adults over 60 years old.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
